Updated Jul 16, 2026
SAUNDERS BRENT L has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $500K. Lifetime open-market sales: $1.71M.

Brent L. Saunders is a prominent executive known for his leadership roles in the healthcare and pharmaceutical industries. He is currently the CEO and Chairman of the Board at Bausch & Lomb Corp, and has previously held significant positions at other companies including Allergan and Bausch Health.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Links | Wikipedia |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-26 | BLCO | Bausch & Lomb Corp | F — Tax withholding / forfeiture | 2.9K | $15.92 | $46K |
| 2026-03-10 | BLCO | Bausch & Lomb Corp | A — Grant or award | 14.7K | $0.00 | |
| 2026-03-10 | BLCO | Bausch & Lomb Corp | P — Open-market purchase | 14.7K | $17.14 | $252K |
| 2026-03-02 | BLCO | Bausch & Lomb Corp | F — Tax withholding / forfeiture | 24.6K | $18.30 | $451K |
| 2026-03-02 | BLCO | Bausch & Lomb Corp | F — Tax withholding / forfeiture | 22.1K | $18.49 | $408K |
| 2026-02-27 | BLCO | Bausch & Lomb Corp | A — Grant or award | 327.1K | $0.00 | |
| 2026-02-25 | BLCO | Bausch & Lomb Corp | F — Tax withholding / forfeiture | 65.4K | $17.99 | $1.18M |
| 2025-08-05 | BLCO | Bausch & Lomb Corp | F — Tax withholding / forfeiture | 4.2K | $14.44 | $61K |
| 2025-06-16 | SKIN | Beauty Health Co | A — Grant or award | 73.1K | — | |
| 2025-05-22 | BLCO | Bausch & Lomb Corp | A — Grant or award | 22.0K | $0.00 | |
| 2025-05-22 | BLCO | Bausch & Lomb Corp | P — Open-market purchase | 22.0K | $11.28 | $248K |
| 2025-05-20 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale | 120.0K | $14.25 | $1.71M |
| 2025-05-20 | SPRY | ARS Pharmaceuticals, Inc. | M — Option exercise | 120.0K | $1.01 | $121K |
| 2024-12-26 | BLCO | Bausch & Lomb Corp | F — Tax withholding / forfeiture | 24.6K | $17.83 | $439K |
| 2024-12-26 | BLCO | Bausch & Lomb Corp | F — Tax withholding / forfeiture | 73.8K | $17.83 | $1.32M |
Brent L. Saunders is a prominent executive known for his leadership roles in the healthcare and pharmaceutical industries. He is currently the CEO and Chairman of the Board at Bausch & Lomb Corp, and has previously held significant positions at other companies including Allergan and Bausch Health.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 2 open-market purchases ($500K) and 1 open-market sales ($1.71M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SAUNDERS BRENT L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.